K. Shinohara

Matthew R Cooperberg, Janet E Cowan, Kirsten L. Greene, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quantified Clinical Risk Change as an End Point During Prostate Cancer Active Surveillance.

M. Cooperberg, P. Carroll, K. Shinohara, 2017, European urology.

Prostate Cancer Predictors of Pathologic Progression on Biopsy Among Men on Active Surveillance for Localized Prostate Cancer : The Value of the Pattern of Surveillance Biopsies

M. Meng, P. Carroll, K. Shinohara, 2013 .

Outcomes of active surveillance for men with intermediate-risk prostate cancer.

Kirsten L. Greene, M. Cooperberg, M. Meng, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer.

K. Shinohara, E. Small, R. Bok, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Utility of PCA3 in patients undergoing repeat biopsy for prostate cancer

M. Cooperberg, K. Shinohara, K Shinohara, 2011, Prostate Cancer and Prostatic Diseases.

Selection of patients for laparoscopic pelvic lymphadenectomy prior to radical prostatectomy: a decision analysis.

P. Carroll, K. Kerlikowske, K. Shinohara, 1993, Urology.

Combined role of transrectal ultrasonography, Gleason score, and prostate-specific antigen in predicting organ-confined prostate cancer.

P. Carroll, K. Shinohara, P. Narayan, 1993, Urology.

Correlation of phospholipid metabolites with prostate cancer pathologic grade, proliferative status and surgical stage – impact of tissue environment

J. Kurhanewicz, D. Vigneron, K. Shinohara, 2011, NMR in biomedicine.

Quantification of choline‐ and ethanolamine‐containing metabolites in human prostate tissues using 1H HR‐MAS total correlation spectroscopy

P. Carroll, J. Kurhanewicz, M. Swanson, 2008, Magnetic resonance in medicine.

Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of carcinoma of the prostate: ethnic variations.

P. Carroll, K. Shinohara, P R Carroll, 1997, The Journal of urology.

Comparison of prostate specific antigen with prostate specific antigen density for 3 clinical applications.

P. Carroll, K. Shinohara, P. Narayan, 1994, The Journal of urology.

Role of penile vascular injury in erectile dysfunction after radical prostatectomy.

F. Bénard, K. Shinohara, P. Narayan, 1994, British journal of urology.

Significance of high-grade prostatic intraepithelial neoplasia on prostate biopsy.

M. Meng, K. Shinohara, G. Grossfeld, 2003, Urologic oncology.

Impact of Staging 68Ga-PSMA-11 PET Scans on Radiation Treatment Plansin Patients With Prostate Cancer.

P. Carroll, I. Hsu, K. Shinohara, 2019, Urology.

Disease-specific survival outcomes in lymph node-positive patients with prostate cancer treated with radiotherapy.

P. Carroll, K. Shinohara, A. Gottschalk, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Serial Anatomical Prostate Ultrasound during Prostate Cancer Active Surveillance.

P. Carroll, K. Shinohara, A. Westphalen, 2016, The Journal of urology.

The utility of apical anterior horn biopsies in prostate cancer detection.

M. Meng, K. Shinohara, J. Presti, 2003, Urologic oncology.

Local anesthesia during 10 core biopsy of the prostate: comparison of 2 methods.

K. Shinohara, A. Matsubara, K. Mita, 2005, The Journal of urology.

Transrectal ultrasound guided prostatic nerve blockade eases systematic needle biopsy of the prostate.

K. Shinohara, P. Nash, K Shinohara, 1996, The Journal of urology.

The importance of tumor palpability and transrectal ultrasonographic appearance in the contemporary clinical staging of prostate cancer.

P. Carroll, K. Shinohara, B. Davies, 2011, Urologic oncology.

Staging of prostate cancer. Accuracy of transrectal ultrasound enhanced by prostate-specific antigen.

K. Shinohara, P. Narayan, J. S. Wolf, 1992, British journal of urology.

Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention

P. Carroll, V. Weinberg, K. Shinohara, 2008, Proceedings of the National Academy of Sciences.

Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer

P. Carroll, V. Weinberg, K. Shinohara, 2010, Cancer Causes & Control.

Local Anesthesia for the Prostate Gland

K. Shinohara, A. Glass, S. Punnen, 2012 .

Best practice statement on cryosurgery for the treatment of localized prostate cancer.

John G Baust, Aaron Katz, Bryan Donnelly, 2008, The Journal of urology.

The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer.

A. Tewari, K. Shinohara, P. Narayan, 1995, Urology.

MRI-ultrasound registration for targeted prostate biopsy

Jasjit S. Suri, John Kurhanewicz, E. David Crawford, 2009, 2009 IEEE International Symposium on Biomedical Imaging: From Nano to Macro.

Magnetic Resonance Imaging-Ultrasound Fusion Biopsy During Prostate Cancer Active Surveillance.

Janet E Cowan, P. Carroll, K. Shinohara, 2017, European urology.

Should cryosurgery be considered a therapeutic option in localized prostate cancer?

P. Carroll, K. Shinohara, J. Presti, 1996, The Urologic clinics of North America.

The use of prostate MR for targeting prostate biopsies

K. Shinohara, A. Westphalen, Hao G Nguyen, 2019, BJR open.

Extended followup and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancer.

Kirsten L. Greene, M. Cooperberg, M. Meng, 2015, The Journal of urology.

Cryosurgical ablation of prostate cancer: patterns of cancer recurrence.

P. Carroll, K. Shinohara, J. Presti, 1997, The Journal of urology.

The significance of prostatic intra-epithelial neoplasia.

P. Carroll, N. Weidner, K. Shinohara, 1995, British journal of urology.

The adjunctive use of power Doppler imaging in the preoperative assessment of prostate cancer

K. Shinohara, J. Cowan, Michael L. Eisenberg, 2010, BJU international.

MP57-11 IMPACT OF LESION VISIBILITY ON TRANSRECTAL ULTRASOUND ON THE PREDICTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER (GLEASON SCORE = 3+4) WITH TRUS-MRI FUSION BIOPSY

P. Carroll, S. Behr, K. Shinohara, 2018 .

Genomic Prostate Score, PI-RADS™ version 2 and Progression in Men with Prostate Cancer on Active Surveillance

M. Cooperberg, P. Carroll, K. Shinohara, 2019, The Journal of urology.

Active surveillance for the management of prostate cancer in a contemporary cohort

M. Cooperberg, M. Meng, P. Carroll, 2008, Cancer.

Feasibility of MR imaging/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer.

I. Hsu, J. Kurhanewicz, K. Shinohara, 2013, International journal of radiation oncology, biology, physics.

US lesion visibility predicts clinically significant upgrade of prostate cancer by systematic biopsy

J. Neuhaus, K. Shinohara, J. Simko, 2022, Abdominal Radiology.

Management of an increasing prostate-specific antigen level after negative prostate biopsy.

K. Shinohara, Hao G Nguyen, S. Masic, 2014, The Urologic clinics of North America.

Prostate Biopsy Techniques

K. Shinohara, 2008 .

The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial.

K. Shinohara, J C Presti, J. Presti, 2000, The Journal of urology.

Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection.

K. Shinohara, J C Presti, J. Presti, 1998, The Journal of urology.

Prospective evaluation of systematic sextant transition zone biopsies in large prostates for cancer detection.

K. Shinohara, C. Montgomery, J. Presti, 1998, Urology.

TRUS Biopsy: Is There Still a Role?

K. Shinohara, M. Leapman, 2016 .

Transrectal Ultrasound-Guided Prostate Biopsy

P. Carroll, K. Shinohara, T. Downs, 2003 .

Thermal ablation of prostate diseases: advantages and limitations

K. Shinohara, K Shinohara, 2004, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Cryosurgical treatment of localized prostate cancer (stages T1 to T4): preliminary results.

P. Carroll, K. Shinohara, J. Presti, 1996, The Journal of urology.

Gene Expression and Biological Pathways in Tissue of Men with Prostate Cancer in a Randomized Clinical Trial of Lycopene and Fish Oil Supplementation

P. Carroll, V. Weinberg, K. Shinohara, 2011, PloS one.

Surgical management after active surveillance for low‐risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment

Kirsten L. Greene, M. Meng, P. Carroll, 2011, BJU international.

Three-dimensional conformal external beam radiotherapy compared with permanent prostate implantation in low-risk prostate cancer based on endorectal magnetic resonance spectroscopy imaging and prostate-specific antigen level.

J. Pouliot, J. Kurhanewicz, K. Shinohara, 2006, International journal of radiation oncology, biology, physics.

Single-fraction brachytherapy as monotherapy for early-stage prostate cancer: The UCSF experience.

I. Hsu, J. Cunha, K. Shinohara, 2018, Brachytherapy.

Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: technique, early toxicity, and PSA response.

I. Hsu, Lijun Ma, V. Weinberg, 2012, International journal of radiation oncology, biology, physics.

Characteristics of Cancer Progression on Serial Biopsy in Men on Active Surveillance for Early-stage Prostate Cancer: Implications for Focal Therapy.

P. Carroll, K. Shinohara, V. Fasulo, 2020, European urology oncology.

A Mobile Health Intervention for Prostate Biopsy Patients Reduces Appointment Cancellations (Preprint)

P. Carroll, K. Shinohara, A. Odisho, 2019 .

Local staging of prostate cancer: comparative accuracy of T2-weighted endorectal MR imaging and transrectal ultrasound.

P. Carroll, J. Kurhanewicz, K. Shinohara, 2012, Clinical imaging.

Comparison of systematic sextant and lesion directed biopsies in prostate cancer detection.

P. Carroll, K. Shinohara, M. Seltzer, 1996, Urologic oncology.

(Non)-migration of radiopaque markers used for on-line localization of the prostate with an electronic portal imaging device.

Jean Pouliot, Katja M Langen, Yu-Ming Liu, 2003, International journal of radiation oncology, biology, physics.

Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR‐MAS spectroscopy of biopsy tissues

J. Kurhanewicz, M. Swanson, S. Nelson, 2008, Magnetic resonance in medicine.

Ultrasonic Determination of Extracapsular Extension: A Clinicopathologic Study

K. Shinohara, T. Wheeler, 1987 .

Comparative analysis of prostate‐specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group

Adam P Dicker, Richard Stock, Steven Frank, 2012, BJU international.

Saw palmetto for benign prostatic hyperplasia.

J. Neuhaus, K. Shinohara, C. Kane, 2006, The New England journal of medicine.

Time to metabolic atrophy after permanent prostate seed implantation based on magnetic resonance spectroscopic imaging.

J. Kurhanewicz, R. T. Ten Haken, K. Shinohara, 2004, International journal of radiation oncology, biology, physics.

Impact of Lesion Visibility on Transrectal Ultrasound on the Prediction of Clinically Significant Prostate Cancer (Gleason Score 3 + 4 or Greater) with Transrectal Ultrasound‐Magnetic Resonance Imaging Fusion Biopsy

P. Carroll, S. Behr, K. Shinohara, 2017, The Journal of urology.

Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate.

K. Shinohara, F Lee, J. Macaluso, 2001, Urology.

Diagnostic Accuracy and Prognostic Value of Serial Prostate Multiparametric Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer.

P. Carroll, K. Shinohara, A. Westphalen, 2021, European urology oncology.

Imaging clinically localized prostate cancer.

M. Meng, P. Carroll, K. Shinohara, 2003, The Urologic clinics of North America.

Radiation therapy for the management of biopsy proved local recurrence after radical prostatectomy.

P. Carroll, K. Shinohara, M. Roach, 1998, The Journal of urology.

Effects of Initial Gleason Grade on Outcomes during Active Surveillance for Prostate Cancer.

M. Cooperberg, P. Carroll, K. Shinohara, 2018, European urology oncology.

Daily electronic portal imaging for morbidly obese men undergoing radiotherapy for localized prostate cancer.

Jean Pouliot, Michele Aubin, J. Pouliot, 2004, International journal of radiation oncology, biology, physics.

Cryosurgery for locally advanced (T3) prostate cancer.

P. Carroll, K. Shinohara, J. Connolly, 1997, Seminars in urologic oncology.

Comparison of transrectal ultrasound prostatic volume estimation with magnetic resonance imaging volume estimation and surgical specimen weight in patients with benign prostatic hyperplasia

A. Tewari, K. Shinohara, C. Anderson, 1996, Journal of clinical ultrasound : JCU.

Staging accuracy of magnetic resonance imaging versus transrectal ultrasound in stages A and B prostatic cancer.

P. Carroll, K. Shinohara, H Hricak, 1994, Urologia internationalis.

The role of metabolic imaging in radiation therapy of prostate cancer

J. Kurhanewicz, D. Vigneron, K. Shinohara, 2014, NMR in biomedicine.

Improved rectal dosimetry with the use of SpaceOAR during high-dose-rate brachytherapy.

J. Cunha, K. Shinohara, L. Boreta, 2017, Brachytherapy.

Comment on: Best Practice Statement on Cryosurgery for the Treatment of Localized Prostate Cancer. Author's reply

David W. Ellis, Richard J. Babaian, Daniel B. Rukstalis, 2009 .

Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy.

M. Kattan, L. Potters, M. Zelefsky, 2009, International journal of radiation oncology, biology, physics.

Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of nonpalpable and stage T1C carcinoma of the prostate.

P. Carroll, K. Shinohara, J. Presti, 1996, The Journal of urology.

Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR‐MAS spectroscopy

P. Carroll, J. Kurhanewicz, M. Swanson, 2010, NMR in biomedicine.

Physical activity and prostate gene expression in men with low-risk prostate cancer

P. Carroll, K. Shinohara, L. Jones, 2014, Cancer Causes & Control.

High-dose-rate brachytherapy for localized prostate adenocarcinoma post abdominoperineal resection of the rectum and pelvic irradiation: Technique and experience.

I. Hsu, V. Weinberg, K. Shinohara, 2009, Brachytherapy.

Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy.

P. Carroll, J. Kurhanewicz, S. Nelson, 1996, Urology.

Prostate carcinoma: MR imaging findings after cryosurgery.

J Kurhanewicz, D B Vigneron, P. Carroll, 1996, Radiology.

Number of positive systematic sextant biopsies predicts surgical margin status at radical prostatectomy.

K. Shinohara, J. Presti, V. Bhargava, 1999, Urology.

Application of Prostate US for Advanced Techniques in Prostate Biopsy and Prostate Cancer Staging

K. Shinohara, 2015 .

Long-term results of NRG Oncology/RTOG 0321 a phase II trial of combined high dose rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate.

I. Hsu, G. Gustafson, H. Sandler, 2019, International journal of radiation oncology, biology, physics.

Equivalent biochemical control and improved prostate-specific antigen nadir after permanent prostate seed implant brachytherapy versus high-dose three-dimensional conformal radiotherapy and high-dose conformal proton beam radiotherapy boost.

I. Hsu, H. Sandler, P. McLaughlin, 2010, International journal of radiation oncology, biology, physics.

Combined modality treatment with high-dose-rate brachytherapy boost for locally advanced prostate cancer.

I. Hsu, V. Weinberg, K. Shinohara, 2005, Brachytherapy.

Toward adaptive stereotactic robotic brachytherapy for prostate cancer: Demonstration of an adaptive workflow incorporating inverse planning and an MR stealth robot

Dan Stoianovici, Jean Pouliot, Galen Reed, 2010, Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy.

Patient- and treatment-specific predictors of genitourinary function after high-dose-rate monotherapy for favorable prostate cancer.

I. Hsu, J. Cunha, K. Shinohara, 2015, Brachytherapy.

Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: potential for dose escalation.

I. Hsu, T. Phillips, K. Shinohara, 2000, International journal of radiation oncology, biology, physics.

The relationship between prostate specific antigen change and biopsy progression in patients on active surveillance for prostate cancer.

Kirsten L. Greene, M. Cooperberg, M. Meng, 2011, The Journal of urology.

OLDER AGE AND TIME TO LAST BIOPSY ARE ASSOCIATED WITH RISE IN GLEASON SCORE FOR MEN ON ACTIVE SURVEILLANCE FOR LOW RISK PROSTATE CANCER

M. Meng, P. Carroll, K. Shinohara, 2008 .

Pre-plan parameters predict post-implant D90 ≥ 140 Gy for 125I permanent prostate implants

V. Weinberg, K. Shinohara, A. Gottschalk, 2014, Journal of contemporary brachytherapy.

Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement.

T. D. de Reijke, J. Chin, E. Crawford, 2023, European urology.

The efficacy of cryosurgical ablation of prostate cancer: the University of California, San Francisco experience.

P. Carroll, K. Shinohara, T. Koppie, 1999, The Journal of urology.

Postoperative nomogram predicting the 9-year probability of prostate cancer recurrence after permanent prostate brachytherapy using radiation dose as a prognostic variable.

M. Kattan, L. Potters, M. Zelefsky, 2010, International journal of radiation oncology, biology, physics.

Positional stability of electromagnetic transponders used for prostate localization and continuous, real-time tracking.

Jean Pouliot, Patrick A Kupelian, James M Balter, 2007, International journal of radiation oncology, biology, physics.

Prediction of focal extracapsular extension at radical prostatectomy: Relative merit of transrectal ultrasound, endorectal magnetic resonance imaging, prostate specific antigen, prostate specific antigen density, and systematic biopsy.

P. Carroll, K. Shinohara, J. Presti, 1996, Urologic oncology.

The value of prostate specific antigen and transrectal ultrasound guided biopsy in detecting prostatic fossa recurrences following radical prostatectomy.

P. Carroll, K. Shinohara, P. Narayan, 1993, The Journal of urology.

High-dose-rate brachytherapy boost for prostate cancer: comparison of two different fractionation schemes.

I. Hsu, V. Weinberg, K. Shinohara, 2008, International journal of radiation oncology, biology, physics.

Daily electronic portal imaging of implanted gold seed fiducials in patients undergoing radiotherapy after radical prostatectomy.

Jean Pouliot, I-Chow Hsu, Michele Aubin, 2005, International journal of radiation oncology, biology, physics.

Technique for Implantation of Fiducial Markers in the Prostate

K. Shinohara, M. Roach, 2007 .

Patterns of Local Failure following Radiation Therapy for Prostate Cancer.

Kirsten L. Greene, P. Carroll, K. Shinohara, 2015, The Journal of urology.

Cryosurgery for the Treatment of Localized Prostate Cancer

R. Babaian, K. Shinohara, J. Thrasher, 2009 .

Prostate cancer: cryotherapy.

K. Shinohara, 2003, The Urologic clinics of North America.

Peak flow rate is the best predictor of acute urinary retention following prostate brachytherapy: Our experience and literature review

K. Shinohara, T. Ikeda, 2009, International journal of urology : official journal of the Japanese Urological Association.

Long-term follow-up of International Prostate Symptom Score (IPSS) in men following prostate brachytherapy

M. Cooperberg, K. Shinohara, T. Lue, 2014, World Journal of Urology.

Transperineal prostate biopsy after abdominoperineal resection.

M. Terris, K. Shinohara, T. Koppie, 2003, The Journal of urology.

Local staging of prostatic carcinoma: comparison of transrectal sonography and endorectal MR imaging.

P. Carroll, K. Shinohara, P. Narayan, 1996, AJR. American journal of roentgenology.

Transrectal Ultrasound-Guided Prostate Biopsy

P. Carroll, K. Shinohara, T. Downs, 2003 .

Cryotherapy

K. Shinohara, 2007, International Journal of Clinical Oncology.

Factors associated with biopsy progression on active surveillance.

Kirsten L. Greene, M. Cooperberg, M. Meng, 2014 .

Original article The utility of apical anterior horn biopsies in prostate cancer detection

M. Meng, K. Shinohara, J. Presti, 2003 .

Salvage high dose rate brachytherapy for recurrent prostate cancer after definitive radiation.

I. Hsu, J. Cunha, G. Valdes, 2021, Practical radiation oncology.

Rationale for minimally invasive interventional techniques in urological cancer

M. Cooperberg, P. Carroll, K. Shinohara, 2011 .

Extended followup and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancer.

Kirsten L. Greene, M. Cooperberg, M. Meng, 2015, The Journal of urology.

A 17-Gene Genomic Prostate Score as a Predictor of Adverse Pathology for Men on Active Surveillance.

M. Cooperberg, P. Carroll, K. Shinohara, 2019, The Journal of urology.

Improving cancer detection by prostate biopsy: the role of core number and site

K. Shinohara, 2006, Nature Clinical Practice Urology.

Effect of a Home-based Walking Intervention on Cardiopulmonary Fitness and Quality of Life Among Men with Prostate Cancer on Active Surveillance: The Active Surveillance Exercise Randomized Controlled Trial.

Stacey A. Kenfield, M. Cooperberg, K. Shinohara, 2023, European urology oncology.

488: Prostate Cancer Progresssion in a Watchful Waiting Cohort: The UCSF Experience

M. Cooperberg, M. Meng, P. Carroll, 2006 .

Cryotherapy

K. Shinohara, 2007, International Journal of Clinical Oncology.

Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR‐MAS spectroscopy

P. Carroll, J. Kurhanewicz, M. Swanson, 2010, NMR in biomedicine.

Magnetic Resonance Imaging-Ultrasound Fusion Biopsy During Prostate Cancer Active Surveillance.

P. Carroll, K. Shinohara, A. Westphalen, 2017, European urology.

Staging of prostate cancer: value of ultrasonography

P. Scardino, K. Shinohara, T. Wheeler, 1989 .

Predictors of pathologic progression on biopsy among men on active surveillance for localized prostate cancer: the value of the pattern of surveillance biopsies.

K. Shinohara, J. Cowan, June M. Chan, 2014, European urology.

Oncology: Prostate/Testis/Penis/Urethra JU Insight Stability of Prognostic Estimation Using the CAPRA Score Incorporating Imaging-based vs Physical Examebased Staging

M. Cooperberg, K. Shinohara, J. Cowan, 2022 .

Prostate volume change after radioactive seed implantation: possible benefit of improved dose volume histogram with perioperative steroid.

I. Hsu, K. Shinohara, J. Speight, 2000, International journal of radiation oncology, biology, physics.

Focal Salvage Cryoablation in Recurrent Prostate Cancer

K. Shinohara, 2011 .

I. Hsu, H. Sandler, V. Weinberg, 2010, International journal of radiation oncology, biology, physics.

Use of magnetic resonance imaging and spectroscopy in the evaluation of external beam radiation therapy for prostate cancer

John Kurhanewicz, J. Kurhanewicz, K. Shinohara, 2003 .

The use of endorectal magnetic resonance spectroscopy imaging (MRSI) to assess the efficacy of post implant dosimetry for permanent prostate implantation

J. Kurhanewicz, K. Shinohara, É. Vigneault, 1998 .

Correlation of phospholipid metabolites with prostate cancer pathologic grade, proliferative status and surgical stage – impact of tissue environment

J. Kurhanewicz, D. Vigneron, K. Shinohara, 2011, NMR in biomedicine.

The relationship between prostate specific antigen change and biopsy progression in patients on active surveillance for prostate cancer.

Kirsten L. Greene, M. Cooperberg, M. Meng, 2011, The Journal of urology.

The adjunctive use of power Doppler imaging in the preoperative assessment of prostate cancer

K. Shinohara, J. Cowan, Michael L. Eisenberg, 2010, BJU international.

The Impact of Delayed Radical Prostatectomy on Recurrence Outcomes After Initial Active Surveillance: Results from a Large Institutional Cohort.

M. Cooperberg, K. Shinohara, J. Cowan, 2023, European urology oncology.

Impact of Staging Ga-PSMA-11 PET Scans on Radiation Treatment Plans in Patients With Prostate Cancer

P. Carroll, I. Hsu, K. Shinohara, 2012 .